Related Experiment Video
Updated: Jun 3, 2026
10:03
Development of Leishmania Species Strains with Constitutive Expression of eGFP
Published on: April 21, 2023
A gp63 based vaccine candidate against Visceral Leishmaniasis
Sukrat Sinha1, Shanthy Sundaram, Anand Prakash Singh
1Center for Biotechnology, University of Allahabad, Allahabad, Uttar Pradesh, India-211002.
Bioinformation
|March 9, 2011
Summary
Visceral leishmaniasis, a macrophage disorder, can be targeted by a gp63-based vaccine. This study found significant conservation in gp63 across Leishmania species, supporting a universal vaccine approach.
Area of Science:
- Immunology
- Parasitology
- Vaccine Development
Background:
- Visceral leishmaniasis is a macrophage-associated disorder.
- It significantly reduces the host's natural immunotherapeutic potential.
- The surface glycoprotein gp63 is a promising vaccine candidate against visceral leishmaniasis.
Purpose of the Study:
- To investigate the similarity and identity of gp63 from different Leishmania species causing visceral leishmaniasis.
- To evaluate the potential of a common gp63-based vaccine for diverse Leishmania strains.
Main Methods:
- Comparative analysis of gp63 sequences from Leishmania donovoni, L. chagasi, and L. infantum.
- Bioinformatic tools including BLAST, Phylogram, and Cladogram studies were employed.
Main Results:
- Significant sequence identity and similarity were observed in the gp63 protein across the studied Leishmania species.
- Key conserved residues essential for protein function were identified.
Conclusions:
- The high conservation of gp63 suggests its potential as a universal vaccine target.
- A common gp63-based vaccine could be a viable therapeutic strategy against visceral leishmaniasis caused by various Leishmania species.
Keywords:
Basic Local Alignment Search Tool (BLAST)CladogramGlycoprotein 63(gp63)PhylogramVisceral leishmaniasis (VL)More Related Videos
Related Concept Videos
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...